Advent Pharma (DHA:ADVENT) EBITDA Margin %: 0.00% (As of . 20)


DHA:ADVENT Advent Pharma Ltd DHA:ADVENT
29 GF Score
Price BDT15.70
View Full Analysis

What is Advent Pharma EBITDA Margin %?

Advent Pharma DHA:ADVENT 29 EBITDA Margin % is 0.00% as of . 20. GuruFocus rates DHA:ADVENT with a GF Score™ of 29/100. Among 955 Drug Manufacturers companies, Advent Pharma ranks worse than 104711.94% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Advent Pharma's EBITDA for the six months ended in . 20 was BDT0.00 Mil. Advent Pharma's Revenue for the six months ended in . 20 was BDT0.00 Mil. Therefore, Advent Pharma's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Advent Pharma  (DHA:ADVENT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Advent Pharma EBITDA Margin % Related Terms

Advent Pharma EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Advent Pharma's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advent Pharma EBITDA Margin % Chart

Advent Pharma Annual Data
Trend
EBITDA Margin %

Advent Pharma Semi-Annual Data
EBITDA Margin %

DHA:ADVENT vs : EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Advent Pharma's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advent Pharma EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Advent Pharma's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Advent Pharma's EBITDA Margin % falls into.


DHA:ADVENT
29GF Score
Advent Pharma Ltd DHA:ADVENT
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advent Pharma EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Advent Pharma's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Advent Pharma's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Advent Pharma (DHA:ADVENT) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Advent Pharma and its competitors. According to the industry distribution chart, Advent Pharma ranks #999999 out of 955 companies in the Drug Manufacturers industry.
Is Advent Pharma's EBITDA Margin % too high?
Advent Pharma's current EBITDA Margin % is 0.00%. Based on the distribution chart, Advent Pharma ranks #999999 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Advent Pharma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Advent Pharma's EBITDA Margin % compare to ?
According to the Drug Manufacturers industry distribution chart, Advent Pharma ranks #999999 out of 955 companies for EBITDA Margin %. This places Advent Pharma in the lower half of its industry. The industry median EBITDA Margin % is 12.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Advent Pharma and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advent Pharma's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advent Pharma stock overvalued right now?
Advent Pharma (DHA:ADVENT) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Advent Pharma's overall GF Score™ is 29/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Advent Pharma (DHA:ADVENT), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advent Pharma Business Description

Comparable Companies
Address Kakrail V.I.P. Road, Level no. 10, 80, Rupayan Karim Tower, Kakrail, Ramna, Dhaka, BGD, 1000
Advent Pharma Ltd is a Bangladesh-based company engaged in producing animal healthcare drugs and nutritional supplements for livestock.
29GF Score

Get the complete analysis for DHA:ADVENT

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT15.70
Price